News

Prerna attended the Fusion conference “Mitochondria & Stem Cell Fate Transitions” in Malta, where she had the opportunity to exchange ideas with researchers and gain insights into how mitochondrial dynamics and metabolic pathways shape stem cell fate decisions. The discussions and perspectives gained from the conference will contribute to her ongoing doctoral research. She thanks the CIBSS Travel Grant Award for supporting her participation in this conference. more

Congratulations to María José Pérez Jiménez, awarded a Klaus Tschira Boost Fund fellowship (up to €120,000) to study how estrogen protects brain cells from mitochondrial stress and why menopause raises Alzheimer's risk in women. Read more on the MPI-IE website. more

María José Pérez Jiménez joined 28 early-career researchers worldwide for the Freiburg Rising Stars Academy Conference Week, connecting with host PIs and the broader Freiburg research community. See the full conference recap here. Photo credit: Rainer Muranyi more

Congratulations to María José Pérez Jiménez, selected for the Freiburg Rising Stars Academy 2025–26 cohort within the CIBSS cluster, pairing her with host mentor Dr. Sukanya Guhathakurta. See the full cohort here. more

Sukanya in an interview with the SFB 1381 about the SFB, here career, balancing of work and private life, gender issues in general. more

Sukanya receives SFB 1381 Young Investigator Grants for excellent early career researchers with great potential for development in academia. Each project is funded with 30.000 Euro for one year and the awardees join the SFB1381 as associated PIs - with the potential of becoming full PIs in the next funding period. more

Congratulations to Sukanya on being awarded a Minerva Fast Track Fellowship from the Max Planck Society, funding three years to establish her own independent research group at MPI-IE. Read the announcement on MPI News more

Our study revealed that MOF, an enzyme best known for regulating genes in the nucleus, also acetylates COX17 in mitochondria to sustain energy production — and that this defect can be partially reversed in patient-derived cells, pointing to new therapeutic avenues. Read the full story … more